Neogen Corporation

NASDAQ:NEOG

Medical - Diagnostics & Research

Healthcare
$11.08 +1.79%

+$0.16 today

Market cap
$2.42B
Beta
1.80
P/E (TTM)
-3.3
EPS (TTM)
-$2.80
52W Low $4.56High $11.43

Volume 1.79M

Average 2.53M

NEOG Common Stock Issued

Cash raised by issuing new shares.

Neogen CorporationNASDAQ: NEOG

Common Stock Issued · Q1 FY2027 · quarter ended Aug 2026

Common stock issued growth accelerates

Q1 FY2027 common stock issued of $2.2M rose 143.1% year over year, ahead of the -32.9% change in trailing-twelve-month common stock issued. Sequentially, it rose 182.8% from the prior quarter. Over 3 fiscal years it compounded at +10.2% a year.

Context

  • Common stock issued amounted to 0.2% of revenue in FY2026, unchanged from a year earlier.
  • Common stock issued increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +143.1% holds above the trailing-twelve-month pace of -32.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterAug 2026
$2.2M+182.8% QoQ
Last fiscal yearMay 2026
$1.6M-28.6% YoY
LTMAug 2026
$2.9M-32.9% YoY
Common Stock Issued past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+143.1%——
1 year-28.6%——
3-year CAGR+10.2%——
5-year CAGR——
10-year CAGR——

Common Stock Issued history

USD · from the cash flow

Latest · FY2026
1.6M USD
Year-over-year change
-28.6%
4-year CAGR
-33.0%

Common Stock Issued vs competitors

How NEOG compares with its peers on the latest reported figures

  • NEOG's LTM Aug 2026 common stock issued of $2.9M is the 4th largest of the 7 companies compared; the peer median is $3.2M.
  • Its year-over-year change of -32.9% is the lowest of 4, against a peer median of +657.6%.
  • Common stock issued amounts to 0.3% of revenue for NEOG, versus a peer median of 0.2%.
NEOG Competitors Peer median
Common Stock Issued for NEOG and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MRKMerck & Co., Inc.LTM Jun 2026$261M +987.5%-37.9%0.4%
IDXXIDEXX Laboratories, Inc.LTM Sep 2026$100.42M +657.6%+37.7%2.2%
BCPCBalchem CorporationLTM Sep 2026$6.39M +22.9%—0.6%
NEOGNeogen CorporationLTM Aug 2026$2.9M -32.9%+10.2%0.3%
ZTSZoetis Inc.LTM Jun 2026$0 ——0.0%
ELANElanco Animal Health IncorporatedLTM Sep 2026$0 ——0.0%
PAHCPhibro Animal Health CorporationLTM Mar 2026$0 ——0.0%
Peer median (excluding NEOG) $3.2M+657.6%-0.1%0.2%

Competitors are the stored peer set for NEOG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
FY2026
May 2026
Net Income48.31M(22.87M)(9.42M)(1.09B)(7.9M)
Depreciation & Amortization24.13M90.47M121.23M125.67M116.3M
Deferred Income Tax(4.7M)(19.23M)(27.42M)(57.78M)(24.3M)
Stock-Based Compensation7.15M10.18M13.77M17.29M13.4M
Change in Working Capital(4.42M)(24.2M)(72.68M)(5.93M)58.8M
Accounts Receivables(7.8M)(53.88M)(20.1M)11.64M6.8M
Inventory(21.07M)9.96M(55.95M)(16.12M)38.2M
Accounts Payables20.24M18.64M13.75M(402K)19.8M
Other Working Capital4.21M1.09M(10.38M)(1.05M)(6M)
Other Non-Cash Items(2.44M)6.67M9.8M1.07B(73.1M)
Operating Cash Flow68.04M41.03M35.26M58.24M83.2M
Capital Expenditures(24.43M)(65.76M)(111.42M)(104.6M)(51.3M)
Acquisitions (Net)(38.75M)12.55M108K5.08M121.7M
Purchases of Investments(415.89M)(12.52M)000
Sales of Investments381.84M266.77M82M325K0
Other Investing Activities0000100K
Investing Cash Flow(97.23M)201.04M(29.31M)(99.2M)70.5M
Debt Repayment0(100M)(420K)(321K)(100M)
Common Stock Issued7.93M1.2M2.46M2.24M1.6M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(1.12M)(19.28M)(118K)(3.52M)(1M)
Financing Cash Flow6.81M(118.08M)1.92M(1.6M)(99.4M)
Effect of Forex Changes(8.75M)(5.22M)(502K)942K2.2M
Net Change in Cash(31.13M)118.77M7.37M(41.61M)56.5M
Free Cash Flow43.61M(24.73M)(76.16M)(46.35M)31.9M

Neogen Corporation

NASDAQ:NEOG

Intrinsic Alpha fair value

Locked

Current Price

$11.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.